cancer drugs

Update news cancer drugs

Cancer drugs could treat rare blood-vessel disorder

 Researchers have found the genetic cause of a blood-vessel disorder that can cause deadly bleeds and stroke.

FDA expands use of AstraZeneca/Merck ovarian cancer drug

 The U.S. Food and Drug Administration on Thursday expanded the use of Lynparza, sold by AstraZeneca Plc and Merck & Co Inc, to include ongoing treatment of patients with recurrent ovarian cancer

AstraZeneca drug wins orphan status in thyroid cancer

 An experimental AstraZeneca drug that failed last year as a treatment for a rare cancer of the eye has been awarded special "orphan" status in the United States for a type of thyroid cancer.